Home
About Us
Issues
Authors
Reviewers
Users
Subscription
Our Other Journals
Neonatal Database
Neonatal Database Download
Neonatal Journal Abstracts
Feedback
Salient Features
Open Access
Editorial Board
Publisher
Publication Ethics & Malpractice
Journal Policy
Peer Review Process
Contact Us
Current Issue
Forthcoming
Article Archive
Access Statistics
Simple Search
Advanced Search
IJNMR Performance
Submit an Article
Instructions
Assistance
Publication Fee
Paid Services
Apply As Reviewer
Acknowledgment
Register Here
Register For Article Submission
Login Here
Login For Article Submission
Annual
Buy One Issue
Payment Options
How to Order
JCDR
IJARS
NJLM

 

Welcome : Guest

Users Online :

 

 

 

 

 

 

 

 

Case report

Year :2023 Month : July Volume : 11 Issue : 3 Page : PC01 - PC03 Full Version

Cardiac Hypertrophy in an Infant of a Diabetic Mother: A Case of Reversible Cardiomyopathy


Basany Laxman, Naga Priyanka Gandrakota, Vinay Batthula, Rajesh Babu Gudipati
1. Consultant Neonatologist, Department of Neonatology, Ankura Hospital for Women and Children, Hyderabad, Telangana, India. 2. Junior Consultant Neonatologist, Department of Neonatology, Ankura Hospital for Women and Children, Hyderabad, Telangana, India. 3. Consultant Neonatologist, Department of Neonatology, Ankura Hospital for Women and Children, Hyderabad, Telangana, India. 4. Consultant Paediatric Cardiologist, Department of Paediatric Cardiology, Star Hospital, Hyderabad, Telangana, India.
 
Correspondence Address :
Dr. Laxman Basany,
Flat 301, B Block, Legend Galaxy, Laxmi Nagar Colony, Kothapet, Hyderabad-500035, Telangana, India.
E-mail: laxmanbasani@yahoo.co.in
 
ABSTRACT

: Diabetes Mellitus (DM) is a chronic metabolic disorder characterised by insulin deficiency or resistance and/or β-cell defects. High Body Mass Index (BMI) at conception, undiagnosed pregestational diabetes, and poor glycaemic control significantly affect the foetal heart, foetoplacental circulation and foetal growth. Myocardial hypertrophy and cardiac defects are more prevalent in Infants of Diabetic Mothers (IDMs). Cardiac Hypertrophy (CH) is characterised by a significant thickening of the interventricular septum, reduction in the size of the ventricular cavity, systolic and diastolic dysfunction and subaortic stenosis. A term neonate born to a mother with pregestational insulin-dependent Type I Diabetes Mellitus (T1DM) developed respiratory distress soon after birth, and Echocardiography (ECHO) showed Asymmetric Septal Hypertrophy (ASH) and Left Ventricular Outflow Tract (LVOT) obstruction. The baby responded well to oral propranolol, which was continued for four weeks, resulting in the resolution of CH at four months of age on follow-up. The present case underscores the importance of ECHO, even in infants born to mothers with good glycaemic control.
Keywords : Cardiomegaly, Diabetes, Hyperinsulinaemia, Macrosomia, Propranolol
DOI and Others : Doi: 10.7860/IJNMR/2023/64417.2389

Date of Submission: Apr 01, 2023
Date of Peer Review: Jun 10, 2023
Date of Acceptance: Jul 05, 2023
Date of Publishing: Sep 30, 2023

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. Yes

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Apr 05, 2023
• Manual Googling: Jun 14, 2023
• iThenticate Software: Jul 08, 2023 (9%)

ETYMOLOGY: Author Origin

EMENDATIONS: 5
 
Case Report

A term male neonate was born to a 29-year-old G2P1L1 mother by elective caesarean section (indication: previous caesarean birth) at 38+3 weeks of gestation. The baby cried immediately with Appearance, Pulse, Grimace, Activity, and Respiration (APGAR) scores of 8 and 9 at one and five minutes, respectively and weighed 3.89 kg (>95th percentile). The mother had insulin-dependent T1DM for the past nine years and had good glycaemic control, and her Glycated Haemoglobin (HbA1c) was 5.9% in the third trimester. Foetal ECHO done at 24 weeks of gestation was normal. The patient had no history of fever, urinary tract infection, or rupture of membranes prior to delivery. The baby had respiratory distress soon after birth and was shifted to the Neonatal Intensive Care Unit (NICU). On examination, the baby was plethoric with features of macrosomia (hairy pinna, thick skin folds, and broad shoulders). Sepsis screen and blood culture were sent, and antibiotics (piperacillin and amikacin) were started. Chest X-ray showed streaky opacities and cardiomegaly (cardiothoracic ratio of 0.70) (Table/Fig 1). The baby required Fraction of Inspired Oxygen (FiO2) of 0.35 to maintain saturation of 91%-95%. Laboratory investigations showed haemoglobin of 16.5 gm/dL, White Blood Cell (WBC): 9,200/cumm, platelets: 1.9 lakhs/cumm, and high C-reactive Protein (CRP) (13 mg/L). Cardiovascular examination revealed a grade III murmur in the lower parasternal area. ECHO at 26 hours of life showed asymmetrical septal hypertrophy, Interventricular septal thickness end diastole: 1.1 cm (z-score=5.1; range 0.26-0.53), Posterior wall thickness end diastole (LVPWd) thickness-0.5 cm (z-score=2.8; range 0.21-0.4), aortic flow-1.0 m/sec, pulmonary flow-1.0 m/sec, moderate LVOT obstruction with a gradient of 40 mmHg, systolic anterior motion of the mitral valve, Mitral E- 0.7 m/sec, Mitral A-0.8 m/sec, and a tiny closing ductus arteriosus (Table/Fig 2). ECHO showed normal diastolic function (E/A 0.87, e’ 0.087, E/e’=8.04).

The infant was started on oral propranolol (1 mg/kg/dose every 8 hourly) with monitoring of blood sugar, heart rate, and blood pressure. Respiratory distress decreased, and the baby was in room air within 48 hours of starting propranolol. Repeat sepsis screen was negative, and antibiotics were stopped at 72 hours. The baby was discharged on day six of life on oral propranolol. Follow-up ECHO at four weeks of life showed IVSd 0.7 cm (z-score=2.9), LVPW thickness 0.4 cm (z-score=1.6), resolution of LVOT obstruction, and propranolol was discontinued (Table/Fig 3). Follow-up ECHO at eight weeks of life showed IVSd 0.5 cm (z-score=1.4). The baby had normal growth and development at four months of age with complete resolution of CH on ECHO (Table/Fig 4).
 
 
Discussion

Despite advances in perinatal care, babies born to mothers with diabetes have high morbidity and mortality (1). Maternal hyperglycaemia causes foetal hyperglycaemia, hyperinsulinaemia, macrosomia and CH. Babies born to mothers with T1DM are at a high risk of developing HCM, followed by Type 2 Diabetes Mellitus (T2DM) and gestational diabetes (2). In infants of IDM, HCM occurs in 50% of infants born to T1DM and 25% of T2DM (3). HCM and congenital hypertrophy are different disorders with varied aetiology. In HCM, the heart muscle is thickened with disruption of myocardial structure, unrelated to hypertension, valvular, or systemic disease (4). CH seen in IDM, Congenital Hyperinsulinism (CHI), leprechaunism, and congenital generalised lipodystrophy is secondary to hyperinsulinism (5). CH is reported in 40% of infants with CHI, 61% of infants with leprechaunism, and in 48% to 61% of patients with congenital generalised lipodystrophy (5). On ECHO, CH is defined as a diastolic septal or left ventricular wall thickness of ≥2 Standard Deviations (SD) above the mean (z-score ≥1.96, corrected for age, gender, and body size), and ASH is defined as an interventricular septum thickness of ≥6 mm and an IVSd/LVPW ratio of ≥1.3 (6).

The CH is symptomatic in 5%-12.1% of IDM, while 40% have asymptomatic CH on ECHO (7). HbA1c correlates poorly with CH, because even transient spikes in glucose can cause cardiac overgrowth. CH involves both ventricles, but septal hypertrophy is more evident due to a greater number of insulin receptors in that area (5). During embryogenesis, hyperglycaemia is teratogenic and can cause structural defects. In late gestation, foetal hyperinsulinaemia increases protein and fat synthesis, glycogen deposition, and leads to hyperplasia and hypertrophy of cardiomyocytes (8). IDM babies should undergo an ECHO, within the first 48 hours of life to assess cardiac function and identify structural malformations. ECHO parameters such as myocardial thickness, shortening fraction, myocardial performance index (Tei index), and mitral and tricuspid valve ratio of the early (E) to late (A) diastolic filling are used to assess cardiac function (9). Thickening of the Interventricular Septum (IVS) and ventricular walls can cause systolic and diastolic dysfunction. Increased left ventricular mass can lead to dynamic LVOT obstruction, by causing the anterior mitral leaflet to appose the IVS. Typically, affected infants recover within two to three weeks, and CH resolves in 6-12 months, as insulin levels normalise. Ujuanbi AS et al., reported a case of CH with LVOT in a term infant, where the LVOT resolved in two to three weeks, similar to the index case (10). Monda E et al., studied 60 IDMs and reported that, CH resolved in one year in 52%, two years in 72%, three years in 79%, and in 100% of cases by six years of age (11). When CH does not improve or worsens, further evaluation is needed to rule out metabolic disorders like pompe disease and genetic disorders like Noonan syndrome. ECHO helps differentiate hyperinsulinism, which causes ASH or LVOT obstruction, from concentric hypertrophy seen in metabolic and neuromuscular disorders (12).

Management of LVOT obstruction includes maintaining adequate intravascular volume and β-adrenergic blockade. β-blockers like propranolol decrease heart rate, reduce myocardial oxygen demand, improve coronary perfusion, and decrease LVOT obstruction (13). The index case had an IVSd of 1.1 cm (z-score=5.1) and moderate LVOT obstruction with a gradient of 40 mmHg, which was treated with propranolol. Dasgupta S et al., reported a term IDM with IVSs of 1.2 cm (z-score=4.5) and LVOT obstruction with a gradient of 25 mmHg, treated with propranolol and milrinone (14). Milrinone, due to its inotropic and lusitropic effects, is used as an adjunct to propranolol with good outcomes (14). Inotropes like dopamine and dobutamine are contraindicated, as they can increase dynamic LVOT obstruction (15). Despite good maternal glycaemic control, this baby developed CH, probably due to transient spikes of hyperglycaemia and the effects of insulin on the placenta.
 
 
Conclusion

The CH in IDM is reversible, but requires monitoring and follow-up. Babies born to mothers with pregestational diabetes and poorly controlled diabetes are at a high risk of CH. A β-blocker like propranolol is recommended for symptomatic neonates. If CH does not resolve or worsens, further evaluation is necessary to rule out metabolic and genetic disorders. With the increasing prevalence of diabetes worldwide, healthcare personnel needs to be more vigilant in detecting and managing DM during pregnancy. Nutritional adaptations in intrauterine life can lead to obesity, diabetes, and cardiovascular diseases in adulthood. The present case emphasises the importance of performing an ECHO, even in infants born to diabetic mothers with good glycaemic control.
 
REFERENCES
1.
Persson B, Hanson U. Neonatal morbidities in gestational diabetes mellitus. Diabetes Care. 1998;21(2):B79-84.   [Google Scholar]
2.
Bogo MA, Pabis JS, Bonchoski AB, Santos DCD, Pinto TJF, Simões MA, et al. Cardiomyopathy and cardiac function in foetuses and newborns of diabetic mothers. J Pediatr (Rio J). 2021;97(5):520-24.   [Google Scholar]  [CrossRef]  [PubMed]
3.
Vela-Huerta MM, Amador-Licona N, Villagomez HVO, Ruiz AH, Guizar-Mendoza JM. Asymmetric septal hypertrophy in appropriate for gestational age infants born to diabetic mothers. Indian Pediatr. 2019;56(4):314-16.   [Google Scholar]  [CrossRef]  [PubMed]
4.
Cordero L, Landon MB. Infant of the diabetic mother. Clinics in Perinatology. 1993;20(3):635-48.   [Google Scholar]  [CrossRef]  [PubMed]
5.
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, et al. Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2008;29(2):270-76.   [Google Scholar]  [CrossRef]  [PubMed]
6.
Paauw ND, Stegeman R, de Vroede MAMJ, Termote JUM, Freund MW, Breur JMPJ. Neonatal cardiac hypertrophy: the role of hyperinsulinism-A review of literature. Eur J Pediatr. 2020;179(1):39-50.   [Google Scholar]  [CrossRef]  [PubMed]
7.
Daubeney PE, Blackstone EH, Weintraub RG, Slavik Z, Scanlon J, Webber SA. Relationship of the dimension of cardiac structures to body size: An echocardiographic study in normal infants and children. Cardiol Young. 1999;9(4):402-10.   [Google Scholar]  [CrossRef]  [PubMed]
8.
Russell NE, Holloway P, Quinn S, Foley M, Kelehan P, McAuliffe FM. Cardiomyopathy and cardiomegaly in stillborn infants of diabetic mothers. Pediatr Dev Pathol. 2008;11(1):10-14.   [Google Scholar]  [CrossRef]  [PubMed]
9.
Sobeih AA, Sakr MMA, Abolmaaty RK. Assessment of cardiac diastolic function in infants of diabetic mothers using tissue Doppler echocardiography. Egypt Pediatric Association Gaz. 2020;68:10.   [Google Scholar]  [CrossRef]
10.
Ujuanbi AS, Onyeka CA, Yeibake WS, Oremodu T, Kunle-Olowu OE, Otaigbe BE. Pathological left ventricular hypertrophy and outflow tract obstruction in an infant of a diabetic mother: A case report. J Cardiol Cardiovasc Med. 2020;5:047-50.   [Google Scholar]  [CrossRef]
11.
Monda E, Verrillo F, Altobelli I, Lioncino M, Caiazza M, Rubino M, et al. Natural history of left ventricular hypertrophy in infants of diabetic mothers. Int J Cardiol. 2022;350:77-82.   [Google Scholar]  [CrossRef]  [PubMed]
12.
Collins JE, Leonard JV. Hyperinsulinism in asphyxiated and small-for- dates infants with hypoglycaemia. Lancet. 1984;2(8398):311-13.   [Google Scholar]  [CrossRef]  [PubMed]
13.
Huang T, Kelly A, Becker SA, Cohen MS, Stanley CA. Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism. Arch Dis Child Fetal Neonatal Ed. 2013;98(4):F351-54.   [Google Scholar]  [CrossRef]  [PubMed]
14.
Dasgupta S, Qasim A, Aly AM, Jain SK. Mother with diabetes mellitus and infant with hypertrophic obstructive cardiomyopathy: Milrinone precluded need for extracorporeal membrane oxygenation. Circ Cardiovasc Imaging. 2017;10(11):e006809.   [Google Scholar]  [CrossRef]  [PubMed]
15.
Gordon EE, Reinking BE, Hu S, Yao J, Kua KL, Younes AK, et al. Maternal hyperglycemia directly and rapidly induces cardiac septal overgrowth in fetal rats. J Diabetes Res. 2015;2015:479565.  [Google Scholar]  [CrossRef]  [PubMed]
 
TABLES AND FIGURES
[Table/Fig-1] [Table/Fig-2] [Table/Fig-3] [Table/Fig-4]
 
 
 

In This Article

  • Abstract
  • Material and Methods
  • Results
  • Discussion
  • Conclusion
  • References

Article Utilities

  • Readers Comments
  • Article in PDF
  • Citation Manager
  • How to Cite
  • Article Statistics
  • Link to PUBMED
  • Print this Article
  • Send to a Friend

Quick Links

REVIEWER
ACCESS STATISTICS
Home  |  About Us  |  Online First  |  Current Issue  |  Simple Search  |  Advance Search  |  Register  |  Login  |  Contact  | 
IJNMR Pre-Publishing  |  Reviewer  |  Articles Archive  |  Access Statistics
© 2023 INDIAN JOURNAL OF NEONATAL MEDICINE & RESEARCH (IJNMR), ISSN : 2277-8527.
EDITORIAL OFFICE : 3rd Floor, Hemraj Jain Building, 4352 Pahari Dhiraj, Delhi, India 110006,Phone : 01123848553

* This Journal is owned and run by medical professionals *